ATE440968T1 - Verfahren zur diagnostizierung von aspirinunverträglichkeit - Google Patents

Verfahren zur diagnostizierung von aspirinunverträglichkeit

Info

Publication number
ATE440968T1
ATE440968T1 AT05810890T AT05810890T ATE440968T1 AT E440968 T1 ATE440968 T1 AT E440968T1 AT 05810890 T AT05810890 T AT 05810890T AT 05810890 T AT05810890 T AT 05810890T AT E440968 T1 ATE440968 T1 AT E440968T1
Authority
AT
Austria
Prior art keywords
aspirine
intolerance
diagnosing
target genes
biological sample
Prior art date
Application number
AT05810890T
Other languages
English (en)
Inventor
Alexandre Pachot
Yves Pacheco
Gilles Devouassoux
Ganse Eric Van
Original Assignee
Biomerieux Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomerieux Sa filed Critical Biomerieux Sa
Application granted granted Critical
Publication of ATE440968T1 publication Critical patent/ATE440968T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
  • Financial Or Insurance-Related Operations Such As Payment And Settlement (AREA)
  • Magnetic Heads (AREA)
  • Valve Device For Special Equipments (AREA)
  • Glass Compositions (AREA)
AT05810890T 2004-10-19 2005-10-17 Verfahren zur diagnostizierung von aspirinunverträglichkeit ATE440968T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0452366A FR2876705B1 (fr) 2004-10-19 2004-10-19 Procede pour le diagnostic d'une intolerance a l'aspirine
PCT/FR2005/050858 WO2006042995A1 (fr) 2004-10-19 2005-10-17 Procédé pour le diagnostic d'une intolérance à l'aspirine

Publications (1)

Publication Number Publication Date
ATE440968T1 true ATE440968T1 (de) 2009-09-15

Family

ID=34950251

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05810890T ATE440968T1 (de) 2004-10-19 2005-10-17 Verfahren zur diagnostizierung von aspirinunverträglichkeit

Country Status (6)

Country Link
US (1) US20080293047A1 (de)
EP (1) EP1802773B1 (de)
AT (1) ATE440968T1 (de)
DE (1) DE602005016290D1 (de)
FR (1) FR2876705B1 (de)
WO (1) WO2006042995A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10254601A1 (de) 2002-11-22 2004-06-03 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
DE102004024617A1 (de) 2004-05-18 2005-12-29 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
EP1790664A1 (de) 2005-11-24 2007-05-30 Ganymed Pharmaceuticals AG Monoklonale Antikörper gegen Claudin-18 zur Behandlung von Krebs
US9719842B2 (en) * 2010-07-06 2017-08-01 Norman A. Paradis Method for the discovery, validation and clinical application of multiplex biomarker algorithms based on optical, physical and/or electromagnetic patterns
WO2013167153A1 (en) 2012-05-09 2013-11-14 Ganymed Pharmaceuticals Ag Antibodies useful in cancer diagnosis

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4672040A (en) * 1983-05-12 1987-06-09 Advanced Magnetics, Inc. Magnetic particles for use in separations
US4683202A (en) * 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4800159A (en) * 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
US4981783A (en) * 1986-04-16 1991-01-01 Montefiore Medical Center Method for detecting pathological conditions
US5750338A (en) * 1986-10-23 1998-05-12 Amoco Corporation Target and background capture methods with amplification for affinity assays
US5700637A (en) * 1988-05-03 1997-12-23 Isis Innovation Limited Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays
US5234809A (en) * 1989-03-23 1993-08-10 Akzo N.V. Process for isolating nucleic acid
US5143854A (en) * 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5744101A (en) * 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
CA2020958C (en) * 1989-07-11 2005-01-11 Daniel L. Kacian Nucleic acid sequence amplification methods
US5807522A (en) * 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
US6506607B1 (en) * 1997-12-24 2003-01-14 Millennium Pharmaceuticals, Inc. Methods and compositions for the identification and assessment of prostate cancer therapies and the diagnosis of prostate cancer
US20050042630A1 (en) * 1999-01-06 2005-02-24 Chondrogene Limited Method for the detection of asthma related gene transcripts in blood
WO2002077186A2 (en) * 2001-03-27 2002-10-03 Human Genome Sciences, Inc. Human secreted proteins
FR2816958B1 (fr) * 2000-11-17 2004-11-26 Biomerieux Sa Procede d'analyse de la predisposition genetique d'un patient au diabete insulino-dependant, dispositif adapte a sa mise en oeuvre et jeu d'amorces d'amplification adapte a un tel procede
AU2002367732A1 (en) * 2001-10-31 2003-09-09 Children's Hospital Medical Center Method for diagnosis and treatment of rheumatoid arthritis
JP2004121218A (ja) * 2002-08-06 2004-04-22 Jenokkusu Soyaku Kenkyusho:Kk 気管支喘息または慢性閉塞性肺疾患の検査方法

Also Published As

Publication number Publication date
EP1802773A1 (de) 2007-07-04
DE602005016290D1 (de) 2009-10-08
EP1802773B1 (de) 2009-08-26
FR2876705B1 (fr) 2008-12-12
WO2006042995A1 (fr) 2006-04-27
FR2876705A1 (fr) 2006-04-21
US20080293047A1 (en) 2008-11-27

Similar Documents

Publication Publication Date Title
Nezhad Future of portable devices for plant pathogen diagnosis
ATE489482T1 (de) Verfahren zur herstellung von hybridsubstraten mit dna und antikörpern sowie verwendungen davon
WO2008115185A3 (en) Use of microarrays for genomic representation selection
EP2003214A3 (de) Reagenzien, Verfahren und Bibliotheken für perlenbasierte Sequenzierung
DE602006012995D1 (de) Brustkrebsdiagnoseverfahren
TW200745556A (en) Biomarkers for liver fibrotic injury
TW200720441A (en) New labelling strategies for the sensitive detection of analytes
ATE515488T1 (de) Click-chemie zur herstellung von reportermolekülen
ATE534748T1 (de) Direkter snp-nachweis mit nichtamplifizierter dna
ATE466107T1 (de) Verfahren und zusammensetzungen zum nachweis von nukleinsäuren in einer biologischen probe
DE60142254D1 (de) Zusammensetzungen, methoden und reagentien zur nukleinsäureisolierung mittels oberflächenaktiven substanzen und proteasen
DE69535802D1 (de) Genetische veränderungen, die mit lungencarzinomen korrelieren
ATE431854T1 (de) Auf bio-barcodes beruhender nachweis von zielanalyten
ATE546550T1 (de) Verfahren zum nachweis von hpv sowie sonden, primer und kits
DE60330842D1 (de) Für den nachweis von nukleinsäuren kompetente biologische rohderivate
EP1978366A4 (de) Fluoreszenzmarker für biologisches material und verfahren zur markierung von biologischem material mit fluoreszenzmarker
ATE491809T1 (de) Amplifikation von dna-fragmenten
ATE440968T1 (de) Verfahren zur diagnostizierung von aspirinunverträglichkeit
ATE542917T1 (de) Zusammensetzungen, verfahren und kits zur bestimmung des vorhandenseins von trichomonas vaginalis in einer testprobe
ATE298804T1 (de) Verfahren zur nachweis von nukleinsäuren
EP1816476A4 (de) Testverfahren für nukleinsäurebindendes protein auf biochipbasis
WO2005054516A3 (en) Peptide nucleic acid probes for analysis of certain staphylococcus species
FR2855832B1 (fr) Procede de diagnostic et/ou de pronostic d'un syndrome septique
ATE537191T1 (de) Protein, verfahren zur proteinimmobilisierung, struktur, biosensor, nukleinsäure, vektor und kit für den nachweis einer zielsubstanz
ATE394417T1 (de) Sonde zum nachweis von nukleinsäuren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties